Investor Relations

Pfenex is a development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology to develop and improve protein therapies.  Pfenex has developed an advanced pipeline of potential therapeutic equivalents, vaccines, and biologics.

Price Data
NYSE AmericanPFNX
Pfenex Corporate Presentation
Terms of Use

The information on this website, including any investor downloads, is not an offer to sell or solicitation of an offer to buy any interest in the company. Any offer of solicitation will be made only by means of a confidential private offering memorandum or registration statement relating to any such interest in the company and solely in those jurisdictions where permitted by law. We ask that you review our “Legal Notice” section of the website, which includes important information you should consider prior to accessing these investor downloads. Downloading these files constitutes your acceptance and understanding of our Legal Notice. The Legal Notice includes important information relating to, among other things, use of and reliance upon the content of this website, our use of forward looking information and other important disclaimers. Please contact us prior to downloading if you have any questions.